Premium
Dynamic molecular changes associated with epithelial–mesenchymal transition and subsequent mesenchymal–epithelial transition in the early phase of metastatic tumor formation
Author(s) -
Aokage Keiju,
Ishii Genichiro,
Ohtaki Yoichi,
Yamaguchi Yoko,
Hishida Tomoyuki,
Yoshida Junji,
Nishimura Mitsuyo,
Nagai Kanji,
Ochiai Atsushi
Publication year - 2011
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.25500
Subject(s) - pathology , epithelial–mesenchymal transition , extravasation , metastasis , cancer cell , cancer , mesenchymal stem cell , lymphovascular invasion , biology , cancer research , medicine
Metastatic tumor formation via vessel route begins with cancer cell extravasation from vessel lumen, migration into the connective tissue surrounding vessels, and invasion into target organ parenchyma. Epithelial–mesenchymal transition (EMT) and mesenchymal–epithelial transition (MET) have been recognized to play an important role in metastatic process, however, how and where these biological changes take place in the early phase of metastatic tumor development has never been clarified. We morphologically evaluated 34 small intrapulmonary metastases formed after cancer cell extravasation from lymphatics (lymphogenic metastasis) and 40 formed in the absence of extravasation (aerogenous metastasis) in human specimens and found that isolated or small clusters of invasive cancer cells (tumor budding) were frequently observed in lymphogenic metastasis (24/34; 71%), but were never observed within aerogenous metastasis. We immunostained 34 lymphogenic metastases for 13 molecular markers of EMT and MET and scored the immunostaining intensity of cancer cells floating in lymphatic vessels (LVs), migrating into the connective tissue surrounding vessels [bronchovascular bundle (BVB)], and growing in lung parenchyma (LP). Cancer cells within BVBs stained more weakly for E‐cadherin ( p < 0.001), β‐catenin ( p < 0.001), and Geminin ( p < 0.001) and more strongly for MMP‐7 ( p = 0.046) and Laminin‐5 γ2 ( p = 0.037) than tumor cells in LVs. However, cancer cells in LP exhibited resurgent E‐cadherin ( p = 0.011), β‐catenin ( p < 0.001), and Geminin ( p = 0.037) expression and reduced MMP‐7 ( p = 0.038) and Laminin‐5 γ2 ( p = 0.001) expression in comparison with cancer cells in BVBs. Our results suggested that in the early phase of metastatic tumor formation cancer cells undergo dynamic phenotypic change associated with EMT and subsequent MET.